Cromoglicic acid
- Generic Name
- Cromoglicic acid
- Brand Names
- Gastrocrom, Nalcrom, Nasalcrom
- Drug Type
- Small Molecule
- Chemical Formula
- C23H16O11
- CAS Number
- 16110-51-3
- Unique Ingredient Identifier
- Y0TK0FS77W
- Background
A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.
- Indication
For the management of patients with bronchial asthma. Also used in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis.
- Associated Conditions
- Asthma, Conjunctivitis, Vernal, Exercise-Induced Bronchospasm, Food Allergy, Keratoconjunctivitis, Perennial Allergic Rhinitis (PAR), Seasonal Allergic Conjunctivitis, Seasonal Allergic Rhinitis, Urticaria Pigmentosa, Vernal Keratoconjunctivitis
- Associated Therapies
- -
Cromolyn Sodium for Treatment of COVID-19 Pneumonia
- Conditions
- Interventions
- First Posted Date
- 2021-10-14
- Last Posted Date
- 2024-11-18
- Target Recruit Count
- 22
- Registration Number
- NCT05077917
- Locations
- 🇺🇸
University Medical Center of El Paso, EL Paso, Texas, United States
Influence of Cromones on Eucapnic Hyperventilation (EVH)-Test in Young (Elite) Athletes Who Tested Positive for EIB.
- Conditions
- Interventions
- First Posted Date
- 2020-05-29
- Last Posted Date
- 2023-08-03
- Lead Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Target Recruit Count
- 8
- Registration Number
- NCT04408664
- Locations
- 🇧🇪
AZ Maria Middelares, Ghent, Belgium
🇧🇪UZ Leuven, Leuven, Vlaams-Brabant, Belgium
Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
- Conditions
- Interventions
- First Posted Date
- 2019-01-04
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Vishwajit Nimgaonkar, MD PhD
- Target Recruit Count
- 160
- Registration Number
- NCT03794076
- Locations
- 🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)
- Conditions
- Interventions
- First Posted Date
- 2017-06-28
- Last Posted Date
- 2022-03-03
- Lead Sponsor
- AZTherapies, Inc.
- Registration Number
- NCT03202147
Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction
- Conditions
- Interventions
- First Posted Date
- 2017-05-25
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 20
- Registration Number
- NCT03167216
- Locations
- 🇺🇸
Northwestern Medical Faculty Foundation, Chicago, Illinois, United States
Mast Cells in Acid-induced Intestinal Permeability
- First Posted Date
- 2016-01-26
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Target Recruit Count
- 20
- Registration Number
- NCT02664051
- Locations
- 🇧🇪
Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven Campus Gasthuisberg O&N1, Leuven, Vlaams Brabant, Belgium
Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)
- Conditions
- Interventions
- First Posted Date
- 2015-10-02
- Last Posted Date
- 2017-08-10
- Lead Sponsor
- Pulmotect, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT02566252
- Locations
- 🇺🇸
WCCT Global, Cypress, California, United States
An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema
- Conditions
- Interventions
- First Posted Date
- 2013-09-02
- Last Posted Date
- 2019-08-07
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 10
- Registration Number
- NCT01933464
- Locations
- 🇺🇸
UCSD Division of Dermatology, San Diego, California, United States
Cromolyn Detection of Silent Aspiration
- Conditions
- Interventions
- First Posted Date
- 2013-04-26
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 16
- Registration Number
- NCT01841307
- Locations
- 🇺🇸
UCSF Airway Clinical Research Center, San Francisco, California, United States
Cromoglicate in Psoriasis
- First Posted Date
- 2012-11-07
- Last Posted Date
- 2022-05-04
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 30
- Registration Number
- NCT01722812
- Locations
- 🇩🇪
Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.